Healthcare

Lysosomal Storage Disorder LSD Market

By Segment, By Region, And Segment Forecasts, 2017 – 2027

Vertical: HealthcareBase Year: 201912 Sections

Executive Summary

Lysosomal Storage Disorder LSD Market — Snapshot

  • Market Size (2017)

    2017

  • Projected (2027)

    2027

  • CAGR (2017–2027)

    N/A

  • Key Players

    107+

Global Lysosomal Storage Disorder (LSD) market is expected to grow at XX% CAGR during the forecast period, 2020-2027

XX

Global Lysosomal Storage Disorder (LSD) Market by Disease Type

XX

Global Lysosomal Storage Disorder (LSD) Market by Therapy Type

XX

Global Lysosomal Storage Disorder (LSD) Market by region

Key Insight

Lysosomal Storage Disorder LSD Market is a key focus area for market intelligence and strategic research.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 4 regions: North America, Europe, Asia Pacific, Rest of the World.
  • Market Segmentation: The market is analyzed across key segments with forecasts from 2017 to 2027.
  • Competitive Landscape: 107 leading companies are profiled, covering market positioning, strategies, and recent developments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Lysosomal Storage Disorder LSD Market — Growth Trajectory

Analysis of Lysosomal Storage Disorder LSD Market from 2017 to 2027. Covers North America, Europe, Asia Pacific, Rest of the World.

Market Share by Application

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • Disease Type Disease Type is broken down into: Lipid Storage Disorder, Glycoprotein Storage Disorder.
  • Therapy Type Therapy Type is broken down into: Enzyme replacement therapy, Substrate reduction therapy, Therapy Type_Others.

Geographic Analysis

Regional market breakdown

  • North America North America is one of the key regions covered in this market analysis.
  • Europe Europe is one of the key regions covered in this market analysis.
  • Asia Pacific Asia Pacific is one of the key regions covered in this market analysis.
  • Rest of the World Rest of the World is one of the key regions covered in this market analysis.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Lysosomal Storage Disorder LSD Market — How We Researched This Market

The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for the forecast period.

After estimating the market sizes and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.

Data Mining

Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the components of the industry and their source, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.

Secondary Research

In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at MRFR have access to some of the most diversified and extensive paid databases, which give us the most accurate data/ information on markets sizes, components, and pricing. Mentioned below is a detailed list of Sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data Sources depending on the need.

Primary Research

In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (SMEs), industry consultants, and C-level executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below.

PRIMARY INTERVIEWS AND INFORMATIONGATHERING PROCESS

Breakdown of Primary Respondents

Forecasting Techniques

We at MRFR follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.

Research Methodology for Market size estimation

Understanding the market in terms of valuation is a crucial task. This becomes significantly important while investing in and choosing the correct business opportunities. In this regard, we at MRFR undertake two market sizing approaches simultaneously, namely, the top-down and bottom-up approaches. In this step, we assess different data points, numeric attributes, information, and industry trends to arrive at the estimates and forecast values for the coming years. We use different mathematical models to estimate the market sizes of different economies and segments, each of which is further summed up to define the total market.

We at MRFR employ a proprietary statistical tool for market estimations, which helps us to arrive at market size estimates and forecasts for different markets and industries.

Bottom-UP approach

In the bottom-up approach, the revenue of key companies and their shares in the market are assessed to deduce the market size. More than 25 key players operating in the Global Lysosomal Storage Disorder (LSD) market are studied. The segmental revenue of each player is analyzed and the size for the Global Lysosomal Storage Disorder (LSD) market is extracted from the segmental/product revenue with the help of secondary and primary research. The extracted size for the market is then validated with industry experts and partner consultants. This derived market size contributes to around 65%–70% of the total global market share in terms of revenue for the Global Lysosomal Storage Disorder (LSD) market. Using the data triangulation method, the overall global market size is estimated.

Top-Down approach

The overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research. The demand-side analysis is conducted, in which the expenditure of major industry players in each region is studied.

The countries considered in the scope of the Global Lysosomal Storage Disorder (LSD) market are the US, Canada, Mexico, the UK, Germany, France, Italy, Spain, China, Japan, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, and Oman, Brazil, Argentina, Chile, and others. However, the number of countries varies according to the market. The figure below depicts the process of market estimation using independent tools employed by our analysts to arrive at the sizing of the market.

As a part of the market engineering, the both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.

Data Triangulation

After arriving at the overall market sizes, the total market is divided into several segments and sub-segments. Again, the market breakdown and data triangulation procedures are implemented, wherever applicable, to complete the overall market engineering process and gather the exact statistics for all segments and sub-segments. The data is triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size is validated using the top-down and bottom-up approaches.

Validation

Validation is the most important stage of the report making process. Validation via an intricately designed feedback process helps us finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic and personal interviews, e-mails, feedback forms, questionnaires, and polling options/answers with a group of relevant industry participants. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models, and conclusions.

  • Base Year

    2019

  • Historical Period

    2017 – 2019

  • Forecast Period

    2019 – 2027

  • Primary Interviews

    150+

Research Process

Historical data (2017–2019) and forecast period (2019–2027)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Lysosomal Storage Disorder LSD Market — Key Findings

Analytical insights on Lysosomal Storage Disorder LSD Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

Lysosomal Storage Disorder LSD Market represents a significant market opportunity with multiple growth drivers across regions and segments.

Market Dynamics

The Lysosomal Storage Disorder LSD Market market encompasses 4 key regions and multiple market segments, with the study period spanning 2017 to 2027.

The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.

Competitive Landscape

This report profiles 107 key companies operating in the Lysosomal Storage Disorder LSD Market market, covering market positioning, product portfolios, and recent developments.

Leading players include Pfizer Inc., Eli Lilly and Company , Lexicon Pharmaceuticals, Inc., Actelion Pharmaceuticals, AMICUS THERAPEUTICS, INC, and 102 others.

Strategic Outlook and Future Directions

Impact on cost of raw materials and products

Impact on availability of products

Impact on production of major manufacturers

Impact on trade (import/export)

Companies

Key companies profiled in Lysosomal Storage Disorder LSD Market

Profiles of 107 companies operating in the Lysosomal Storage Disorder LSD Market market, including revenue, employee count, and market positioning where available.

Showing 107 of 107 companies

Pfizer Inc

Pfizer Inc.

Food & Beverages

Company Headquarters: New York, US Founded: 1849 Workforce: ~83,000 Company Working: Pfizer Inc. (Pfizer) is a leading research-based biopharmaceutical company that applies science and resources to provide innovative treatments that extend and significantly improve lives. Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, clinics, government agencies, and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. Furthermore, the company supplies its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East.

Revenue$41.7B
Employees83,000
Market CapN/A
Founded1848
New York, US
AstraZenec

AstraZeneca

Healthcare

Company Headquarters: Cambridge, UK Founded: 1999 Workforce: 83,100 Company Working: AstraZeneca is a leading biopharmaceutical company. It focuses on developing and commercializing prescribed medicines. It has three main therapy areas, namely, cardiovascular, and metabolic disease (CVMD), oncology, and respiratory. It is also active in areas such as neuroscience autoimmunity and infection. It has more than 164 projects in its pipeline, nine new molecular entities in its late-stage pipeline, and one new molecular entity approval in the last quarter of 2019. Its product portfolio includes medications in the field of oncology, cardiovascular, renal & metabolism, and respiratory diseases, among others. Geographically the company operates in more than 100 countries by offering its healthcare products to millions of people across the globe.

Revenue$21.0B
Employees83,100
Market CapN/A
Founded1998
Cambridge, UK
Eli Lilly

Eli Lilly and Company

Healthcare

Company Headquarter: ‎ Indianapolis, Indiana, US Founded: 1876 Workforce: 42,066 Company Working: Eli Lilly and Company is an American global pharmaceutical company. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company is listed on the New York Stock Exchange, and its shares had been a component of the S&P 500 Index since 1971. Lilly was the first company to mass-produce penicillin, the Salk polio vaccine, and insulin. Its achievements include being one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin, Humalog, and the first approved biosimilar insulin product in the US, Basaglar. Lilly is also the world's largest manufacturer and distributor of psychiatric medications including Prozac (Fluoxetine), Dolophine (Methadone), Cymbalta (Duloxetine), and Zyprexa (olanzapine). Some of the top competitors of Eli Lilly and Company are Pfizer Inc., GlaxoSmithKline PLC, Biogen, Sanofi, and Johnson and Johnson.

Revenue$21.2B
Employees42,066
Market CapN/A
Founded1875
United States, North America
Merck KGaA

Merck KGaA

Healthcare

Company Headquarters: Darmstadt, Germany Founded: 1668 Workforce: ~60,348 Company Working: Merck KGaA (Merck) is a pharmaceutical company that offers a varied range of products subgrouped into three segments—healthcare, life sciences, and performance materials. The company delivers innovative health solutions and is dedicated to providing breakthrough solutions and technologies. The company research drugs in the areas of oncology and neurodegenerative as well as autoimmune and inflammatory diseases. It also markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for industries such as pharmaceuticals, food, cosmetics, packaging, and coatings. It has expanded its global footprint through several mergers and acquisitions, such as the acquisition of Millipore and Sigma-Aldrich. The company is distributing its products in the following countries: China, India, Japan, Australia, Israel, United Arab Emirates, South Korea, Denmark, Italy, Netherlands, Spain, United Kingdom, Switzerland, Sweden, Argentina, Brazil, Canada, US, New Zealand among others.

Revenue$21.5B
Employees60,348
Market CapN/A
Founded1667
Darmstadt, Germany
Arena Phar

Arena Pharmaceuticals

Healthcare

Arena Pharmaceuticals — Healthcare

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Actelion P

Actelion Pharmaceuticals

Healthcare

Actelion Pharmaceuticals — Healthcare

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Page 1 of 18
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Lysosomal Storage Disorder LSD Market

Starting from
$4,950